The Sentante Endovascular Robotic System has hit a major milestone, completing its first in human clinical study led by Dainis Krievins, MD, PhD in Riga, Latvia. Over three weeks, 10 patients underwent 21 fully robotic procedures!
Sentante‘s fully robotic, remote-operated system shields medical teams from radiation while ensuring precision with haptic feedback. This breakthrough promises to transform endovascular treatment, enhancing safety for patients and healthcare providers.
Get ready for Sentante‘s global launch next year!
Categories
Successful Human Trial Completed!
